Logo

Nectar Lifesciences Share Price

Nectar Lifesciences (INR)39.5-0.6   (-1.6%)

Exchange ScripsBSE532649NSENECLIFEISININE023H01027

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Nectar Lifesciences Performance

Market performance
Open price40.02
High40.02
Volumes2449116
Prev Close39.5
Low39.33
Closing date2024-12-26
Historical performance
1 Year High56.50
3 Year High56.50
5 Year High56.50
1 Year Low26.15
3 Year Low14.50
5 Year Low7.10

Nectar Lifesciences Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
886
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
177.37
Dividend Yield
Dividend Yield
N/A

Nectar Lifesciences Investment Returns

1 Year
16.3%
3 Years
50.8%
5 Years
219.8%
10 Years
20.2%

Nectar Lifesciences Technicals

IndicatorsValueSignal
5-DMA41.01Bearish
10-DMA40.76Bearish
20-DMA37.39Bullish
50-DMA36.39Bullish
100-DMA38.18Bullish
200-DMA35.35Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters22222
Foreign Investors---------------
Domestic Investors22222
Public Investors6673858227599436075860280
Government11111

Nectar Lifesciences Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income243531113114
Operating Profit1759106116991128
Interest9698947881120
Depreciation607591570603
Profit Before Tax183-424341-848
Consolidated Net Profit50-242250-733
Adjusted EPS----11-3

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital224224224224
Total Reserves10468104221065510396
Minority Interest------------
Total Non-Current Liabilities1415213129631264
Total Liabilities21836216862388023758
Capital Work in Progress658778851986
Total Assets21836216862388023758

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities22471337950214
Cash Flow from Investing Activities-170517166-286
Cash Flow from Financing Activitie-2054-1856-1194115
Net Cash Inflow / Outflow22-2-7742
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 177.37.
  • 3Y Stock Price CAGR of the stock is 14.5.
  • The stock has a beta of 0.8.
  • In the last financial year, the company had an EBITDA of ₹1759 Million.
  • The company generated revenue of ₹16841 Million in the previous financial year.

Nectar Lifesciences

39.5-0.6   (-1.6%)

Investment Amount: ₹ 3315
Current Value: ₹ 3950
Performance: 19.2%
P/L: ₹ 635
Top Gainers
SymbolChange%
INDOUS328.05(20%)
SAURASHCEM125.29(19%)
GALAPREC1353.05(18%)
INTELLECT1051.9(15%)
TAJGVK402.95(14%)
Top Losers
SymbolChange%
BPL107.21(-10%)
SAMPANN40.25(-9%)
SADHNANIQ42.69(-8%)
ARCHIDPLY115.21(-8%)
SADBHIN6.45(-7%)
DEEPINDS544.7(-7%)
MOKSH18.61(-7%)
VERTOZ13.59(-7%)
Similar stocks

Zota Health Care

50

836.2

November 26 - December 26

Bajaj Healthcare

38.6

552.9

November 26 - December 26

Ind-Swift

27

26.03

November 26 - December 26

Lincoln Pharma

25.2

786.7

November 26 - December 26

Bliss GVS Pharma

20.9

161.81

November 26 - December 26

Brooks Laboratories

19

169.76

November 26 - December 26

Vineet Laboratories

18.4

59.54

November 26 - December 26

Lasa Supergenerics

17.4

28.17

November 26 - December 26

Announcing Stock of the Month!

Stock of the Month
Stock of the Month